ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 166 filers reported holding ESPERION THERAPEUTICS INC NE in Q1 2019. The put-call ratio across all filers is 1.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $24 | -99.9% | 3,800 | -1.9% | 0.00% | – |
Q3 2022 | $31,000 | +29.2% | 3,874 | +1.9% | 0.00% | – |
Q2 2022 | $24,000 | +33.3% | 3,800 | 0.0% | 0.00% | – |
Q1 2022 | $18,000 | +260.0% | 3,800 | +838.3% | 0.00% | – |
Q3 2021 | $5,000 | -44.4% | 405 | 0.0% | 0.00% | – |
Q2 2021 | $9,000 | -86.6% | 405 | -83.2% | 0.00% | – |
Q1 2021 | $67,000 | +6.3% | 2,405 | 0.0% | 0.00% | – |
Q4 2020 | $63,000 | +600.0% | 2,405 | +843.1% | 0.00% | – |
Q3 2020 | $9,000 | -30.8% | 255 | 0.0% | 0.00% | – |
Q2 2020 | $13,000 | +116.7% | 255 | +27.5% | 0.00% | – |
Q1 2020 | $6,000 | -50.0% | 200 | 0.0% | 0.00% | – |
Q4 2019 | $12,000 | +71.4% | 200 | 0.0% | 0.00% | – |
Q3 2019 | $7,000 | +16.7% | 200 | +53.8% | 0.00% | – |
Q2 2019 | $6,000 | +20.0% | 130 | 0.0% | 0.00% | – |
Q1 2019 | $5,000 | -16.7% | 130 | 0.0% | 0.00% | – |
Q4 2018 | $6,000 | 0.0% | 130 | 0.0% | 0.00% | – |
Q3 2018 | $6,000 | -40.0% | 130 | -50.0% | 0.00% | – |
Q2 2018 | $10,000 | -9.1% | 260 | +73.3% | 0.00% | – |
Q1 2018 | $11,000 | -31.2% | 150 | -40.0% | 0.00% | – |
Q4 2017 | $16,000 | – | 250 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Meditor Group Ltd | 4,468,835 | $27,840,842 | 18.82% |
Ikarian Capital, LLC | 1,891,147 | $11,781,846 | 2.84% |
Altium Capital Management LP | 620,000 | $3,862,600 | 1.96% |
Ikarian Capital, LLC | 1,296,900 | $8,079,687 | 1.95% |
Parkman Healthcare Partners LLC | 822,784 | $5,125,944 | 1.36% |
Deep Track Capital, LP | 4,000,000 | $24,920,000 | 1.05% |
Monaco Asset Management SAM | 470,100 | $2,928,723 | 0.88% |
BRAIDWELL LP | 3,393,405 | $21,140,913 | 0.71% |
Telemetry Investments, L.L.C. | 71,000 | $442 | 0.70% |
Rhenman & Partners Asset Management AB | 900,000 | $5,607,000 | 0.58% |